Hydroxychloroquine and Remdesivir in COVID-19: A critical analysis of recent events.
Indian J Med Ethics
; V(3): 202-207, 2020.
Article
in English
| MEDLINE | ID: covidwho-966218
ABSTRACT
The world is going through an unprecedented medical emergency with no effective remedy for the SARS-CoV2 virus causing Covid-19. Two drugs used for other indications in the past, hydroxychloroquine (HCQ) and remdesivir (RDV), are sought to be repurposed to treat Covid-19. Both these drugs have received emergency use authorisation by the US Food and Drug Administration. In this review, we critically analyse the identification of and subsequent events concerning these two drugs as potential treatment options for Covid-19, and conclude by raising some ethical issues that require serious thought from the global scientific community concerned with using these two drugs against Covid-19.Key Words Covid-19, hydroxychloroquine, remdesivir, USFDA, emergency use authorisation
.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Adenosine Monophosphate
/
Alanine
/
Emergencies
/
Ethics
/
COVID-19 Drug Treatment
/
Hydroxychloroquine
Type of study:
Prognostic study
/
Reviews
Limits:
Humans
Language:
English
Journal:
Indian J Med Ethics
Journal subject:
Ethics
Year:
2020
Document Type:
Article
Affiliation country:
Ijme.2020.068
Similar
MEDLINE
...
LILACS
LIS